Offering minimally-invasive, low-risk treatment for Prostate Cancer and BPH.
Are you concerned about an Elevated PSA, Prostate Cancer, or BPH?
Take our interactive questionnaire to see tailored information after answering 7 questions or less.
Prostate cancer is the second most common form of cancer in men and the second most common cause of cancer deaths in men. Almost as many men die of prostate cancer as women die of breast cancer. Fortunately, breakthroughs in 3T multiparametric MRI now allow for better diagnosis and precise treatment of prostate cancer.
Benign prostatic hypertrophy (BPH) often occurs as men age, making it difficult to urinate. A weak stream, delayed initiation, and waking up at night are all symptoms. With 3T multiparametric MRI, we can now precisely target and treat the problem areas with no hospital stay, less trauma, and 1/20th of the average blood loss of the surgical "gold standard."
Prostate mpMRI and Guided Focal Laser Ablation for Prostate Cancer
This video begins by describing the diagnosis of prostate cancer starting with a TRUS biopsy vs MRI. It then describes the advantages and disadvantages of different treatment approaches and provides examples of images from focal laser ablation cases.
Meet the Specialists
Dr. Ara Karamanian
Ara Karamanian, MD is a board certified diagnostic and interventional radiologist specializing in prostate cancer.
Donnie Sartin, RN, BSN, CRN, CSRN
Donnie Sartin has extensive experience with focal laser ablation with hundreds of patients dating back to 2013.
Featured Patient Testimonial: Wayne Gregory
Family, safety, and preserving quality of life were top of mind for Wayne Gregory when he chose laser focal therapy, also known as focal laser ablation (FLA), to treat his prostate cancer.
“I had lesions ultimately on both sides of the prostate near the nerve bundles,” said Gregory. “I knew that the skill and precision it was going to take to get that cancer ablated was going to have to be very, very high.”